Search Results
ASH Highlights 2016 – Reversing Direct Oral Anticoagulants
ASH Highlights 2016 – Safety of Direct Oral Anticoagulants in Patients of Extreme Weight
ASH Highlights 2016 – After the Bleed: When and How to Restart Anticoagulants
Reversing Direct Oral Anticoagulants
Reversal Agents for Direct Oral Anticoagulants
Reversal of Direct Oral Anticoagulants
Drug Monitoring and Reversal Agents for Direct Oral Anticoagulants
The Blessing and Curse of Direct Oral Anticoagulants in the Bleeding Patient
ASH Highlights 2016 – Costs Associated with VTE in Cancer Patients Treated with Anticoagulants
Direct Oral Anticoagulants (DOACs) and the impact of 'antidotes' - CardioEd Lecture
Reversing DOACs: Providing Answers on Why, When, and How
ASH 2013 - Mark Crowther, M.D., on Andexanet Alpha and anticoagulant agents
